Stocktoria
Vyome Holdings, Inc HIND
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-10-06
Vyome Holdings, Inc statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 68.4% | 2.4% | 63.9% | 60.5% | 61.4% |
| Operating margin | -3269.4% | -12.6% | -177.3% | -412.4% | -425.6% |
| Net margin | -3209.7% | -18.1% | -131.2% | -411.2% | -464.3% |
| Return on assets | -157.9% | -104.8% | -106.8% | -414.8% | -120.2% |
| Return on equity | -272.8% | 33.0% | -170.9% | -1262.3% | -142.4% |
| Current ratio | 1.99 | 0.05 | 2.73 | 1.32 | 3.98 |
| Revenue growth | -96.0% | -7.7% | -22.8% | -17.4% | 20.4% |
Source: SEC EDGAR filings · CIK 0001427570 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.